For women with chronic inflammatory diseases, diagnosis and treatment initiation often overlap with peak reproductive years. High disease activity is associated with increased risk of pregnancy complications and adverse outcomes; disease control is important for patients (pts). Tumor necrosis factor antagonists (anti-TNFs) are effective, but use among Women of Childbearing Age (WoCBA) is variable. This survey aimed to help understand perceptions of healthcare professionals (HCPs) of treating WoCBA pts.